2CV Stock Overview Engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
ConvaTec Group PLC Competitors Price History & Performance
Summary of share price highs, lows and changes for ConvaTec Group Historical stock prices Current Share Price UK£2.92 52 Week High UK£3.44 52 Week Low UK£2.52 Beta 0.67 1 Month Change 1.39% 3 Month Change -0.68% 1 Year Change 2.10% 3 Year Change 40.38% 5 Year Change 13.97% Change since IPO 17.74%
Recent News & Updates
ConvaTec Group PLC to Report Fiscal Year 2024 Results on Feb 26, 2025 Dec 17
New minor risk - Share price stability Nov 13
Investor sentiment improves as stock rises 20% Nov 13
Upcoming dividend of UK£0.014 per share Aug 16
First half dividend of UK£0.014 announced Aug 02
First half 2024 earnings released: EPS: US$0.038 (vs US$0.027 in 1H 2023) Aug 01 See more updates
ConvaTec Group PLC to Report Fiscal Year 2024 Results on Feb 26, 2025 Dec 17
New minor risk - Share price stability Nov 13
Investor sentiment improves as stock rises 20% Nov 13
Upcoming dividend of UK£0.014 per share Aug 16
First half dividend of UK£0.014 announced Aug 02
First half 2024 earnings released: EPS: US$0.038 (vs US$0.027 in 1H 2023) Aug 01
ConvaTec Group PLC Provides Revenue Guidance for the Full Year 2024 May 17
Upcoming dividend of UK£0.035 per share Apr 18
Convatec Launches New Esteem Body with Leak Defense Apr 16 ConvaTec Group plc Recommends Final Dividend, Payable on 23 May 2024
Full year 2023 earnings released: EPS: US$0.064 (vs US$0.031 in FY 2022) Mar 07
ConvaTec Group PLC, Annual General Meeting, May 16, 2024 Mar 06
ConvaTec Group PLC to Report First Half, 2024 Results on Jul 30, 2024 Feb 16
Now 20% undervalued Feb 15
Now 21% undervalued Jan 05
ConvaTec Group PLC Revises Earnings Guidance for the Year 2023 Nov 14
ConvaTec Group PLC to Report Fiscal Year 2023 Results on Mar 06, 2024 Sep 14 An unknown buyer acquired an unknown minority stake in ConvaTec Group PLC from Novo Holdings A/S.
Upcoming dividend of UK£0.014 per share at 2.1% yield Aug 10 ConvaTec Group plc Declares Interim Dividend for the Six Months Ended June 30, 2023
New major risk - Financial position Aug 03
First half 2023 earnings released: EPS: US$0.027 (vs US$0.024 in 1H 2022) Aug 03
Now 20% undervalued Jul 24
Now 20% undervalued after recent price drop Jul 06
ConvaTec Group PLC Provides Revenue Guidance for the Year 2023 May 19
Upcoming dividend of UK£0.037 per share at 2.2% yield Mar 30
Full year 2022 earnings released: EPS: US$0.031 (vs US$0.059 in FY 2021) Mar 10
Group CFO & Director recently bought €73k worth of stock Dec 24
ConvaTec Group Plc to Report Fiscal Year 2022 Results on Mar 09, 2023 Dec 14
High number of new directors Nov 17
ConvaTec Group plc Provides Revenue Guidance for the Full Year of 2022 Nov 10
Now 20% undervalued after recent price drop Nov 03 ConvaTec Group Plc(LSE:CTEC) dropped from FTSE 250 Index
Now 20% undervalued after recent price drop Sep 03
Upcoming dividend of UK£0.014 per share Aug 18
First half 2022 earnings released Aug 05 Convatec Group plc Declares an Unchanged Interim Dividend for First Half of 2022
ConvaTec Group Plc Provides Earnings Guidance for the Full Year 2022 May 12
High number of new directors Apr 27
Upcoming dividend of UK£0.032 per share Mar 24
Convatec Group plc Proposes Final Dividend for Year 2021, Payable on May 19, 2022 Mar 10
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Mar 09
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Mar 09
Convatec Group plc Announces Board Changes Mar 01
ConvaTec Group Plc (LSE:CTEC) agreed to acquire Triad Life Sciences, Inc. for $450 million. Jan 30
ConvaTec Group Plc Appoints Constantin Coussios as Member of Remuneration Committee and Nomination Committee Jan 28
Upcoming dividend of UK£0.012 per share Aug 26
First half 2021 earnings released: EPS US$0.043 (vs US$0.03 in 1H 2020) Aug 01
Company Secretary has left the company May 04
ConvaTec Group plc Provides Financial Guidance for the Year 2021 Apr 29
Upcoming dividend of UK£0.028 per share Mar 26
Full year 2020 earnings released: EPS US$0.056 (vs US$0.005 in FY 2019) Mar 24
Full year 2020 earnings released: EPS US$0.056 (vs US$0.005 in FY 2019) Mar 06
Revenue beats expectations Mar 06
Convatec Group Plc, Annual General Meeting, May 07, 2021 Mar 05
Convatec Group Plc to Report Fiscal Year 2020 Results on Mar 05, 2021 Feb 23
New 90-day low: €2.16 Feb 23
New 90-day high: €2.30 Feb 04
New 90-day high: €2.25 Nov 11
Convatec Group plc Revises Revenue Guidance for the Year 2020 Oct 29
New 90-day low: €1.90 Oct 07 Medline Industries, Inc. completed the acquisition of Aloe Vesta and SensiCare Skin Care Business of Convatec Group Plc (LSE:CTEC).
Convatec Group Plc announced that it has received funding from The Carlyle Group Inc. Sep 24
New 90-day low: €1.95 Sep 22 Convatec Group Plc (LSE:CTEC) completed the acquisition of asset of Southlake Medical Supplies, Inc. for $12.3 million.
New 90-day low - €2.07 Sep 05 Shareholder Returns 2CV DE Medical Equipment DE Market 7D 3.5% 1.4% 2.7% 1Y 2.1% -2.8% 17.0%
See full shareholder returns
Return vs Market: 2CV underperformed the German Market which returned 17% over the past year.
Price Volatility Is 2CV's price volatile compared to industry and market? 2CV volatility 2CV Average Weekly Movement 3.1% Medical Equipment Industry Average Movement 6.9% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.1% 10% least volatile stocks in DE Market 2.5%
Stable Share Price: 2CV has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 2CV's weekly volatility (3%) has been stable over the past year.
About the Company ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.
Show more ConvaTec Group PLC Fundamentals Summary How do ConvaTec Group's earnings and revenue compare to its market cap? 2CV fundamental statistics Market cap €5.97b Earnings (TTM ) €146.00m Revenue (TTM ) €2.10b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 2CV income statement (TTM ) Revenue US$2.20b Cost of Revenue US$970.50m Gross Profit US$1.23b Other Expenses US$1.08b Earnings US$153.20m
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 26, 2025
Earnings per share (EPS) 0.075 Gross Margin 55.89% Net Profit Margin 6.96% Debt/Equity Ratio 80.4%
How did 2CV perform over the long term?
See historical performance and comparison Dividends
2.0% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/16 14:28 End of Day Share Price 2025/02/14 00:00 Earnings 2024/06/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources ConvaTec Group PLC is covered by 35 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Hassan Al-Wakeel Barclays Samuel England Berenberg Marianne Bulot BofA Global Research
Show 32 more analysts 
